Patency in Arteriovenous Grafts in Hemodialysis Patients

Abstract

Objective:

It is difficult to maintain a working access for patients on hemodialysis. Despite current Dialysis Outcome Quality Initiatives recommendations of “Fistula First,” not everyone qualifies for a fistula, and those patients undergoing the alternative treatment, a graft, can experience graft failure. This study examines factors associated with arteriovenous graft (AVG) patency.

Methods:

A retrospective analysis was completed for all the patients who had an AVG during 2005 to 2010. Data were collected from electronic medical records, including date of first and subsequent interventions, salvage technique (surgical vs percutaneous), medical comorbidities, and use of antiplatelet medications (aspirin and clopidogrel). Continuous variables were compared with 2 sample t tests, and categorical variables with chi-square/Fisher exact test. Logistic regression was used to determine the odds ratio for risk factors associated with patency. A P value of <.05 was considered significant. All analyses were done using SAS 9.2 (SAS Institute Inc, Cary, North Carolina).

Results:

A total of 193 unique patients had an AVG. Of the 193 patients, 64% were female, 83% were hypertensive, and 64% were diabetic. The locations of the grafts were 80% arm, 15% forearm, and 5% thigh. Configurations, including loop and straight, were 34% and 63%, respectively. Comorbidities were not associated with patency. Primary patency was not found to be different with respect to location and configuration of graft and type of intervention. Primary patency for patients taking only aspirin (n = 43) and only clopidogrel (n = 17) were significantly different from patients on a combination of aspirin and clopidogrel (n = 7), with a P = .0051 and P = .0447, respectively.

Conclusion:

Neither location nor configuration affects the primary patency of AVGs. Aspirin alone is not inferior to aspirin and clopidogrel. Further prospective studies may be warranted to establish a consensus regarding medications and patency with AVGs.

Keywords

hemodialysis renal failure clopidogrel aspirin percutaneous patency surgical looped straight primary secondary

Get full access to this article

View all access options for this article.

References

Macdougall

Eckardt

Locatelli

. Latest US KDOQI Anaemia Guidelines update—what are the implications for Europe? Nephrol Dial Transplant. 2007;22(10):2738–2742.

KDOQI. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50(3):471–530.

KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12–S154.

Woo

Doros

Farber

. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts. J Vasc Surg. 2009;50(6):1405–1411.e1401–e1402.

Dutka

Brickel

. A practical review of the kidney dialysis outcomes quality initiative (KDOQI) guidelines for hemodialysis catheters and their potential impact on patient care. Nephrol Nurs J. 2010;37(5):531–535.

Collins

Foley

Herzog

: United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis. 2009;53(suppl 1):S1–S374.

Vassalotti

Falk

Cohl

Uribarri

Teodorescu

. Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clin Nephrol. 2002;58(3):211–214.

Collins

Foley

Herzog

. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011;57(1 suppl 1):A8, e1–A8, e526.

Sidawy

Spergel

Besarab

. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg. 2008;48(suppl 5):2S–25S.

10.

Bia

Adey

Bloom

. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Kidney Dis. 2010;56(2):189–218.

11.

Hallan

Orth

SR.

The KDOQI 2002 classification of chronic kidney disease: for whom the bell tolls. Nephrol Dial Transplant. 2010;25(9):2832–2836.

12.

Kramer

. The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) Grant Initiative: moving clinical practice forward. Am J Kidney Dis. 2010;55(3):411–414.

13.

Uhlig

Berns

Kestenbaum

. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2010;55(5):773–799.

14.

Dixon

Beck

Vazquez

. Effect of Dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009;360(21):2191–2201.

15.

Kaufman

O'Connor

Zhang

. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol. 2003;14(9):2313–2321.

16.

Kaufman

. Use of aspirin in hemodialysis patients. Semin Dial. 2001;14(1):72–73.

17.

Feldman

Kobrin

Wasserstein

. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7(4):523–535.

18.

Trimarchi

Young

Forrester

. Clopidogrel diminishes hemodialysis access graft thrombosis. J Vasc Access. 2005;6(1):29–33.

19.

Duran

Canbaz

Ege

. Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting. Platelets. 2001;12(8):503–504.

20.

Davie

Love

. CAPRIE trial. Lancet. 1997;349(9048):355.

21.

Eriksson

. Creative cost-effectiveness analysis of CAPRIE data-dust in our eyes. Am J Med. 2005;118(2):199–200.

22.

Allon

Stent graft or balloon angioplasty alone for dialysis-access grafts. N Engl J Med. 2010;362(20):1939.

23.

Crowther

Clase

Margetts

. Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol. 2002;13(9):2331–2337.

24.

Schmitz

McCloud

Reikes

Leonard

Gellens

. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol. 2002;13(1):184–190.

25.

Lok

Allon

Donnelly

. Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study. Clin Trials. 2007;4(4):357–367.

26.

Vergili-Nelsen

. Benefits of fish oil supplementation for hemodialysis patients. J Am Diet Assoc. 2003;103(9):1174–1177.

27.

Azar

Dequiedt

Awada

. Effects of fish oil rich in polyunsaturated fatty acids on hyperlipidemia of hemodialysis patients. Kidney Int Suppl. 1989;27:S239–S242.

28.

Hamazaki

Nakazawa

Tateno

. Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients. Kidney Int. 1984;26(1):81–84.

29.

Monroy-Cuadros

Yilmaz

Salazar-Bañuelos

Doig

. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol. 2010;5(10):1787–1792.

30.

Tsai

Chen

Hwang

Chang

Lin

Chen

. Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients. Am J Kidney Dis. 2010;55(5):856–866.

31.

Cull

Carsten

CG III

Kalbaugh

. The reverse J arteriovenous graft configuration for hemodialysis access: rationale, technique, and outcomes. Am Surg. 2008;74(7):620–624.

32.

Santoro

Cambria

RA.

PTFE shunts for hemodialysis access: progressive choice of configuration. Semin Vasc Surg. 1997;10(3):166–174.

33.

Yoffe

Behar

Scheinowitz

. A new mechanical device for declotting of hemodialysis access grafts: first clinical experience. J Endovasc Ther. 2005;12(2):215–223.

34.

Turmel-Rodrigues

Raynaud

Louail

Beyssen

Sapoval

. Manual catheter-directed aspiration and other thrombectomy techniques for declotting native fistulas for hemodialysis. J Vasc Interv Radiol. 2001;12(12):1365–1371.

35.

Turmel-Rodrigues

LA.

Hemodialysis graft declotting with the “lyse and wait” technique: a new name for an old recipe. J Vasc Interv Radiol. 1999;10(1):96–98.

36.

Turmel-Rodrigues

. Hemodialysis access declotting: a native fistula is not a prosthetic graft. J Vasc Interv Radiol. 2000;11(1):135–137.

37.

Enea

Swank

MD.

Hemodialysis graft declotting: “lyse and wait” and watch. J Vasc Interv Radiol. 1998;9(4):660–661.

38.

Cynamon

Lakritz

Wahl

. Hemodialysis graft declotting: description of the “lyse and wait” technique. J Vasc Interv Radiol. 1997;8(5):825–829.

39.

Dana

Davy

Druecke

Rethers

Michel

. Angiography by the arterial route of arteriovenous fistula in hemodialysis patients [in French]. Ann Radiol (Paris). 1983;26(5):359–364.